Cargando…
Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347634/ https://www.ncbi.nlm.nih.gov/pubmed/35491441 http://dx.doi.org/10.1111/all.15334 |
| _version_ | 1784761867628969984 |
|---|---|
| author | Francis, Charles H. R. Hearn, Andrew P. Ratnakumar, Sharenja Taylor, Alexander Duckitt, Jordan Ahmed, Usmaan Dhariwal, Jaideep Nanzer, Alexandra M. Jackson, David J. |
| author_facet | Francis, Charles H. R. Hearn, Andrew P. Ratnakumar, Sharenja Taylor, Alexander Duckitt, Jordan Ahmed, Usmaan Dhariwal, Jaideep Nanzer, Alexandra M. Jackson, David J. |
| author_sort | Francis, Charles H. R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9347634 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93476342022-08-03 Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab Francis, Charles H. R. Hearn, Andrew P. Ratnakumar, Sharenja Taylor, Alexander Duckitt, Jordan Ahmed, Usmaan Dhariwal, Jaideep Nanzer, Alexandra M. Jackson, David J. Allergy Letters to the Editor John Wiley and Sons Inc. 2022-05-11 /pmc/articles/PMC9347634/ /pubmed/35491441 http://dx.doi.org/10.1111/all.15334 Text en © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Francis, Charles H. R. Hearn, Andrew P. Ratnakumar, Sharenja Taylor, Alexander Duckitt, Jordan Ahmed, Usmaan Dhariwal, Jaideep Nanzer, Alexandra M. Jackson, David J. Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab |
| title | Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab |
| title_full | Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab |
| title_fullStr | Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab |
| title_full_unstemmed | Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab |
| title_short | Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab |
| title_sort | covid‐19 in the absence of eosinophils: the outcome of confirmed sars‐cov‐2 infection whilst on treatment with benralizumab |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347634/ https://www.ncbi.nlm.nih.gov/pubmed/35491441 http://dx.doi.org/10.1111/all.15334 |
| work_keys_str_mv | AT francischarleshr covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab AT hearnandrewp covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab AT ratnakumarsharenja covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab AT tayloralexander covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab AT duckittjordan covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab AT ahmedusmaan covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab AT dhariwaljaideep covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab AT nanzeralexandram covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab AT jacksondavidj covid19intheabsenceofeosinophilstheoutcomeofconfirmedsarscov2infectionwhilstontreatmentwithbenralizumab |